Publications

Export 44 results:
Sort by: Author Title Type [ Year (Desc)]
2015
Tayel SA, Nabarawi MA, Tadros MI, Abd-Elsalam WH. Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. Int J Pharm. 2015;483(1-2):77-88.
Yehia SA, El-Ridi MS, Tadros MI, El-Sherif NG. Enhancement of the oral bioavailability of fexofenadine hydrochloride via Cremophor EL-based liquisolid tablets. Adv. Pharm. Bull . 2015;5(4):569-81.
Tadros MI, Al-mahallawi AM. Long-circulating lipoprotein-mimic nanoparticles for smart intravenous delivery of a practically-insoluble antineoplastic drug: Development, preliminary safety evaluations and preclinical pharmacokinetic studies. Int J Pharm. 2015;493(1-2):439-50.
Yehia SA, El-Ridi MS, Tadros MI, El-Sherif NG. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers. Pharm Dev Technol. 2015;20(5):528-39.
2014
Tadros MI, Fahmy RH. Controlled-release triple anti-inflammatory therapy based on novel gastroretentive sponges: Characterization and magnetic resonance imaging in healthy volunteers. Int J Pharm. 2014;472(1-2):27-39.
2013
Abdelbary GA, Tadros MI. Brain targeting of olanzapine via intranasal delivery of core - shell difunctional block copolymer mixed nanomicellar carriers: in-vitro characterization, ex-vivo estimation of nasal toxicity and in-vivo biodistribution studies. Int J Pharm. 2013;452(1-2):300-10.
Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Positively charged polymeric nanoparticle reservoirs of Terbinafine hydrochloride: Preclinical implications for controlled drug delivery in the aqueous humor of rabbits. AAPS PharmSciTech. 2013;14(2):782-93.
Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013;443(1-2):293-305.
Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Sucrose stearate-enriched lipid matrix tablets of etodolac: modulation of drug release, diffusional modeling and structure elucidation studies. AAPS PharmSciTech. 2013;14(2):656-68.
2011
Ghorab DM, Amin MM, Khowessah OM, Tadros MI. Colon-targeted celecoxib-loaded Eudragit(®) S100-coated poly-ϵ-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats. Drug Del. 2011;18 (7):523-35.
Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets. AAPS PharmSciTech. 2011;12(2):485-95.
ElMeshad AN, Tadros MI. Transdermal delivery of an anti-cancer drug via w/o emulsions based on alkyl polyglycosides and lecithin: design, characterization and in vivo evaluation of the possible irritation potential in rats. AAPSPharmSciTech. 2011;12 (1):1-9.
2010
Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74(2):332-9.
2008
Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm. 2008;69(3):1018-28.
Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm. 2008;357 (1- 2):189-98.
2007
Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPSPharmSciTech. 2007;8(4):E1-E8.
Foda NH, El-laithy HM, Tadros MI. Implantable biodegradable sponges: effect of inter-polymer complex formation of chitosan with gelatin on the release behavior of tramadol hydrochloride. Drug Dev Ind Pharm. 2007;33(1):7-17.
Abd-Elbary A, El-laithy HM, Tadros MI. Promising ternary dry powder inhaler formulations of cromolyn Sodium: formulation and in vitro – in vivo evaluation. Arch Pharm Res. 2007;30(6):785-92.
2004
Foda NH, El-laithy HM, Tadros MI. Optimization of biodegradable sponges as controlled release drug matrices: I. effect of moisture level on chitosan sponge mechanical properties. Drug Dev Ind Pharm. 2004;30(4):369-79.
Tourism